TAIM
CVS icon

TD Ameritrade Investment Management’s CVS Health CVS Stock Holding History

TD Ameritrade Investment Management’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-3,531
Closed -$244K – 103
2023
Q2 		$244K Sell
3,531
-814
-19% -$57.9K ﹤0.01% 154
2023
Q1 		$323K Sell
4,345
-1,376
-24% -$115K ﹤0.01% 142
2022
Q4 		$533K Sell
5,721
-1,772
-24% -$171K 0.01% 127
2022
Q3 		$715K Sell
7,493
-4,484
-37% -$444K 0.01% 125
2022
Q2 		$1.11M Sell
11,977
-3,145
-21% -$307K 0.01% 119
2022
Q1 		$1.53M Buy
15,122
+1,051
+7% +$110K 0.01% 117
2021
Q4 		$1.45M Sell
14,071
-1,521
-10% -$141K 0.01% 112
2021
Q3 		$911K Buy
15,592
+2,655
+21% +$222K 0.01% 118
2021
Q2 		$1.08M Buy
12,937
+322
+3% +$26.4K 0.01% 117
2021
Q1 		$862K Hold
12,615
– – 0.01% 118
2020
Q4 		$862K Sell
12,615
-2,977
-19% -$194K 0.01% 118
2020
Q3 		$911K Sell
15,592
-1,026
-6% -$63.8K 0.01% 118
2020
Q2 		$1.08M Sell
16,618
-2,103
-11% -$132K 0.01% 116
2020
Q1 		$1.11M Sell
18,721
-1,187
-6% -$79.2K 0.01% 110
2019
Q4 		$1.48M Buy
19,908
+2,061
+12% +$145K 0.01% 110
2019
Q3 		$1.13M Buy
17,847
+3,037
+21% +$180K 0.01% 117
2019
Q2 		$807K Buy
14,810
+6,901
+87% +$372K 0.01% 127
2019
Q1 		$427K Buy
7,909
+5,689
+256% +$351K ﹤0.01% 142
2018
Q4 		$145K Buy
2,220
+1,817
+451% +$136K ﹤0.01% 173
2018
Q3 		$32K Buy
403
+327
+430% +$23.4K ﹤0.01% 237
2018
Q2 		$5K Buy
+76
New +$5.01K ﹤0.01% 259

Other funds holding CVS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

TD Ameritrade Investment Management's CVS Position: Q3 2023 in Review

TD Ameritrade Investment Management sold out of CVS Health (CVS) in Q3 2023, closing a stake of 3,531 shares — an estimated $244K sold.

TD Ameritrade Investment Management first reported a position in CVS in Q2 2018 and held it in 21 quarters. The position peaked at $1.53M in Q1 2022. 2,113 funds tracked by Wall St. Rank hold CVS as of Q3 2023.

  • TD Ameritrade Investment Management reported no remaining CVS Health position as of Q3 2023 after selling out during the quarter.
  • TD Ameritrade Investment Management sold 3,531 CVS Health shares in Q3 2023, an estimated $244K.
  • TD Ameritrade Investment Management first reported a position in CVS Health in Q2 2018 and held it in 21 quarters.
  • TD Ameritrade Investment Management's CVS Health position peaked at $1.53M in Q1 2022.
  • 2,113 funds tracked by Wall St. Rank held CVS Health as of Q3 2023.

Based on TD Ameritrade Investment Management's 13F filing for Q3 2023.